Acute effect of H.E.L.P. treatment on radical scavenging enzyme activities, total glutathione concentrations in granulocytes, and selenium in plasma
- 1 January 2000
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 30 (1) , 26-32
- https://doi.org/10.1046/j.1365-2362.2000.00583.x
Abstract
Background: It has been suggested that granulocytes are activated on artificial surfaces such as dialyzer membranes or by plasma separation procedures resulting in the generation of free radicals. We reported recently that free radical scavenging enzyme (FRSE) activities of red blood cells obtained from patients undergoing hemodialysis and LDL‐apheresis (LA) do not reflect an acute oxidative stress. However, because mature red cells are free of DNA and RNA, enzymes cannot be regulated on the gene level. In contrast, granulocytes are nucleated cells in which genes can be regulated, e.g. by redox sensitive transcription factors activated by extracellular oxidative stress. Therefore, granulocyte FRSE may better reflect acute oxidative stress caused by extracorporeal treatment.Materials and methods: Hyperlipidemic patients (n = 18) with coronary heart disease (CHD) were treated with the Heparin‐induced‐Extracorporeal‐LDL‐Precipitation (H.E.L.P.) system. Glutathione peroxidase (GSH‐Px), glutathione reductase (GSSG‐R), superoxide dismutase (SOD) activities, and total glutathione were determined in granulocytes before and immediately after a single LA treatment. Selenium (Se) concentrations were assessed in plasma.Results: As a result of the H.E.L.P. treatment GSSG‐R activity was significantly induced (+ 20%) and the GSH concentration increased (+ 41%) in granulocytes. GSH‐Px activity in granulocytes (– 19%) and Se in plasma (– 27%) were significantly reduced whereas SOD activity in granulocytes was not affected by the H.E.L.P. procedure.Conclusion: These results show that the defence against oxygen radicals in granulocytes is affected but not severely compromised in patients undergoing regular H.E.L.P‐LDL‐apheresis treatment, which points to the safety of this system with respect to oxidative stress.Keywords
This publication has 26 references indexed in Scilit:
- The role of oxidized lipoproteins in atherogenesisPublished by Elsevier ,1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- LDL-Apheresis Atherosclerosis Regression Study (LAARS)Circulation, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL‐cholesterol plasma concentrations and the course of coronary heart disease*European Journal of Clinical Investigation, 1994
- Reactive Oxygen Species Production by Monocytes and Polymorphonuclear Leukocytes During DialysisAmerican Journal of Kidney Diseases, 1991
- Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole bloodKidney International, 1985